Cargando…

Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms

Axial symptoms emerge in a significant proportion of patients with Parkinson's disease (PD) within 5 years of deep brain stimulation (STN-DBS). Lowering the stimulation frequency may reduce these symptoms. The objectives of the current study were to establish the relationship between gait perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Giulio, Irene, Kalliolia, Eirini, Georgiev, Dejan, Peters, Amy L., Voyce, Daniel C., Akram, Harith, Foltynie, Thomas, Limousin, Patricia, Day, Brian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375830/
https://www.ncbi.nlm.nih.gov/pubmed/30800094
http://dx.doi.org/10.3389/fneur.2019.00029
_version_ 1783395427231465472
author Di Giulio, Irene
Kalliolia, Eirini
Georgiev, Dejan
Peters, Amy L.
Voyce, Daniel C.
Akram, Harith
Foltynie, Thomas
Limousin, Patricia
Day, Brian L.
author_facet Di Giulio, Irene
Kalliolia, Eirini
Georgiev, Dejan
Peters, Amy L.
Voyce, Daniel C.
Akram, Harith
Foltynie, Thomas
Limousin, Patricia
Day, Brian L.
author_sort Di Giulio, Irene
collection PubMed
description Axial symptoms emerge in a significant proportion of patients with Parkinson's disease (PD) within 5 years of deep brain stimulation (STN-DBS). Lowering the stimulation frequency may reduce these symptoms. The objectives of the current study were to establish the relationship between gait performance and STN-DBS frequency in chronically stimulated patients with PD, and to identify factors underlying variability in this relationship. Twenty-four patients treated chronically with STN-DBS (>4 years) were studied off-medication. The effect of stimulation frequency (40–140 Hz, 20 Hz-steps, constant energy) on gait was assessed in 6 sessions spread over 1 day. Half of the trials/session involved walking through a narrow doorway. The influence of stimulation voltage was investigated separately in 10 patients. Gait was measured using 3D motion capture and axial symptoms severity was assessed clinically. A novel statistical method established the optimal frequency(ies) for each patient by operating on frequency-tuning curves for multiple gait parameters. Narrowly-tuned optimal frequencies (20 Hz bandwidth) were found in 79% of patients. Frequency change produced a larger effect on gait performance than voltage change. Optimal frequency varied between patients (between 60 and 140 Hz). Contact site in the right STN and severity of axial symptoms were independent predictors of optimal frequency (P = 0.009), with lower frequencies associated with more dorsal contacts and worse axial symptoms. We conclude that gait performance is sensitive to small changes in STN-DBS frequency. The optimal frequency varies considerably between patients and is associated with electrode contact site and severity of axial symptoms. Between-subject variability of optimal frequency may stem from variable pathology outside the basal ganglia.
format Online
Article
Text
id pubmed-6375830
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63758302019-02-22 Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms Di Giulio, Irene Kalliolia, Eirini Georgiev, Dejan Peters, Amy L. Voyce, Daniel C. Akram, Harith Foltynie, Thomas Limousin, Patricia Day, Brian L. Front Neurol Neurology Axial symptoms emerge in a significant proportion of patients with Parkinson's disease (PD) within 5 years of deep brain stimulation (STN-DBS). Lowering the stimulation frequency may reduce these symptoms. The objectives of the current study were to establish the relationship between gait performance and STN-DBS frequency in chronically stimulated patients with PD, and to identify factors underlying variability in this relationship. Twenty-four patients treated chronically with STN-DBS (>4 years) were studied off-medication. The effect of stimulation frequency (40–140 Hz, 20 Hz-steps, constant energy) on gait was assessed in 6 sessions spread over 1 day. Half of the trials/session involved walking through a narrow doorway. The influence of stimulation voltage was investigated separately in 10 patients. Gait was measured using 3D motion capture and axial symptoms severity was assessed clinically. A novel statistical method established the optimal frequency(ies) for each patient by operating on frequency-tuning curves for multiple gait parameters. Narrowly-tuned optimal frequencies (20 Hz bandwidth) were found in 79% of patients. Frequency change produced a larger effect on gait performance than voltage change. Optimal frequency varied between patients (between 60 and 140 Hz). Contact site in the right STN and severity of axial symptoms were independent predictors of optimal frequency (P = 0.009), with lower frequencies associated with more dorsal contacts and worse axial symptoms. We conclude that gait performance is sensitive to small changes in STN-DBS frequency. The optimal frequency varies considerably between patients and is associated with electrode contact site and severity of axial symptoms. Between-subject variability of optimal frequency may stem from variable pathology outside the basal ganglia. Frontiers Media S.A. 2019-02-08 /pmc/articles/PMC6375830/ /pubmed/30800094 http://dx.doi.org/10.3389/fneur.2019.00029 Text en Copyright © 2019 Di Giulio, Kalliolia, Georgiev, Peters, Voyce, Akram, Foltynie, Limousin and Day. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Di Giulio, Irene
Kalliolia, Eirini
Georgiev, Dejan
Peters, Amy L.
Voyce, Daniel C.
Akram, Harith
Foltynie, Thomas
Limousin, Patricia
Day, Brian L.
Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms
title Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms
title_full Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms
title_fullStr Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms
title_full_unstemmed Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms
title_short Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease: Optimal Frequency for Gait Depends on Stimulation Site and Axial Symptoms
title_sort chronic subthalamic nucleus stimulation in parkinson's disease: optimal frequency for gait depends on stimulation site and axial symptoms
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375830/
https://www.ncbi.nlm.nih.gov/pubmed/30800094
http://dx.doi.org/10.3389/fneur.2019.00029
work_keys_str_mv AT digiulioirene chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms
AT kallioliaeirini chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms
AT georgievdejan chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms
AT petersamyl chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms
AT voycedanielc chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms
AT akramharith chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms
AT foltyniethomas chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms
AT limousinpatricia chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms
AT daybrianl chronicsubthalamicnucleusstimulationinparkinsonsdiseaseoptimalfrequencyforgaitdependsonstimulationsiteandaxialsymptoms